Turnabout Is Fair Play: SAC Sues Company That Sued It

Feb 22 2010 | 11:04am ET

If you’re going to do battle with SAC Capital Advisors, you’d better win. The Connecticut hedge fund giant last week sued a pharmaceutical company that had accused it of conspiring to drive down its stock price.

SAC filed suit in Connecticut federal court against Biovail, accusing the Canadian company of filing a “vexatious” lawsuit against it in 2006. That suit was tossed last year by a New Jersey judge.

According to SAC’s complaint, the Biovail allegations led to “tens of millions of dollars in unnecessary legal fees,” which it seeks to recoup, as well as “incalculable damages to its reputation.” The hedge fund is seeking triple damages.

One of SAC’s co-defendants in the Biovail case, research firm Gradient Analytics, also sued the pharmaceutical last week.

Biovail characterized the two lawsuits against it as “unfortunate.”


In Depth

'Smart Beta' Funds In Regulators' Sights, Hedgies May Be Next

Mar 26 2015 | 11:11am ET

Funds that mimic strategies used by active managers for a fraction of the cost could...

Lifestyle

Study: Both Marriage and Divorce Lead to Negative Hedge Fund Performance

Mar 25 2015 | 6:51pm ET

Trouble at home leads to trouble in the market for fund managers, according to researchers...

Guest Contributor

Concerned About Your HFT Exposure? Hedge It!

Mar 26 2015 | 1:06pm ET

High-frequency trading has been a persistent storyline for several years. The trading...

 

Sponsored Content

    Mar 9 2015 | 6:35am ET

    Kelly RodriquesKelly RodriquesAs more investors look to diversify, many are beginning to use retirement funds to invest in alternative assets such as private equity and real estate. Kelly Rodriques, CEO & President of PENSCO Trust Company, explains how companies can connect with those looking to use their retirement accounts in a different way. Read more…

Editor's Note